Thomas Idorn
- Endocrinology, Diabetes and Metabolism top 0.5%
- Surgery top 5%
- Molecular Biology
- Pharmacology top 2%
- Nephrology top 2%
- Co-authors
- Johannes F.E. MannPeter RossingKenneth W. MahaffeyGeorge L. BakrisKatherine R. TuttleRichard PratleyFlorian M.M. BaeresHeidrun Bosch‐Traberg
- Topics
- Diabetes Treatment and Management (35 papers)Metabolism, Diabetes, and Cancer (15 papers)Diabetes Management and Research (9 papers)
- Partner nations
- DenmarkUnited StatesAustralia
In The Last Decade
Thomas Idorn
43 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Endocrinology, Diabetes and Metabolism 1.6k
- Surgery 645
- Molecular Biology 498
- Pharmacology 367
- Nephrology 317
Countries citing papers authored by Thomas Idorn
This map shows the geographic impact of Thomas Idorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Idorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Idorn more than expected).
Fields of papers citing papers by Thomas Idorn
This network shows the impact of papers produced by Thomas Idorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Idorn. The network helps show where Thomas Idorn may publish in the future.
Co-authorship network of co-authors of Thomas Idorn
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Idorn. A scholar is included among the top collaborators of Thomas Idorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Idorn. Thomas Idorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trialbreakdown → | 50 |
| 3 | Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialbreakdown → | 74 |
| 4 | 1 | |
| 5 | Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetesbreakdown → | 656 |
| 6 | 20 | |
| 7 | 15 | |
| 8 | 4 | |
| 9 | The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasebreakdown → | 147 |
| 10 | 13 | |
| 11 | 14 | |
| 12 | 4 | |
| 13 | 12 | |
| 14 | Abstract 15035: Liraglutide Reduces Major Cardiovascular Events in Patients With Chronic Kidney Disease: Results From the Leader Trial | 1 |
| 15 | 15 | |
| 16 | 13 | |
| 17 | 26 | |
| 18 | 13 | |
| 19 | 14 | |
| 20 | 27 |
About Thomas Idorn
Thomas Idorn is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Complementary and Manual Therapy, having authored 44 papers that have together received 2.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (35 papers), Metabolism, Diabetes, and Cancer (15 papers) and Diabetes Management and Research (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Nephrology (317 citations) and Pharmacology (367 citations). Thomas Idorn has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Johannes F.E. Mann, Peter Rossing, Kenneth W. Mahaffey, George L. Bakris, Katherine R. Tuttle, Richard Pratley, Florian M.M. Baeres, Heidrun Bosch‐Traberg, Vlado Perkovic and Nanna L. Lausvig. Their work appears in journals such as New England Journal of Medicine, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.